Dr. Patrik De Haes, CEO, Oxurion discusses the need for new treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.  About half of patients living with diabetic eye disease respond poorly or do not respond at all to the current standard of care.  Oxurion is working to advance its clinical development and is partnering with advocacy groups around the world to increase patients' access to potential therapies. @Oxurion Oxurion.com